Samia Elouali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samia Elouali has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Mohammed Rhazi
Interdisciplinary Laboratory in Bio-Resources, Environment and Materials, Higher Normal School, Cadi Ayyad University, Marrakech, Morocco
8 shared publicationsNadia Eladlani
Interdisciplinary Laboratory in Bio-Resources, Environment and Materials, Higher Normal School, Cadi Ayyad University, Marrakech, Morocco
6 shared publicationsYoussef Ait Hamdan
Interdisciplinary Laboratory in Bio-Resources, Environment and Materials, Higher Normal School, Cadi Ayyad University, Marrakech, Morocco
5 shared publications- Youssef Ait Hamdan
Cadi Ayyad University, Morocco
5 shared publications Hassane Oudadesse
University of Rennes, France
3 shared publicationsKamal Smimih
Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Mococco
3 shared publications
Latest Publications
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 205-232
Therapeutic Implications of Chitosan and Its Derivatives
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 205-232
Therapeutic Implications of Chitosan and Its Derivatives
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.
- 3 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 285, 138302
Extraction of chitin and chitosan from Hermetia illucens breeding waste: A greener approach for industrial application
- 3 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 285, 138302
Extraction of chitin and chitosan from Hermetia illucens breeding waste: A greener approach for industrial application
- 9 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 281, 136449
Green chitosan extraction from Hermetia illucens breeding waste (prepupal cases): Characterization and bioadsorption activity
- 9 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 281, 136449
Green chitosan extraction from Hermetia illucens breeding waste (prepupal cases): Characterization and bioadsorption activity
- 16 September 2024
- Published by Springer Nature in Euro-Mediterranean Journal for Environmental Integration
- Vol. 10 (1) , 25-36
Chitosan from Periplaneta americana L.: a sustainable solution for heavy metals removal
- 16 September 2024
- Published by Springer Nature in Euro-Mediterranean Journal for Environmental Integration
- Vol. 10 (1) , 25-36
Chitosan from Periplaneta americana L.: a sustainable solution for heavy metals removal
- 25 July 2024
- Published by Springer Nature in Euro-Mediterranean Journal for Environmental Integration
- Vol. 9 (4) , 2095-2107
Exploring the potential use of chitosan derived from Hermetia illucens waste for olive oil mill wastewater treatment
- 25 July 2024
- Published by Springer Nature in Euro-Mediterranean Journal for Environmental Integration
- Vol. 9 (4) , 2095-2107
Exploring the potential use of chitosan derived from Hermetia illucens waste for olive oil mill wastewater treatment
- 18 December 2023
- Published by IGI Global Scientific Publishing
- p. 375-399
Investigation of Potential Neuroprotective Role of Chitosan-Based Biomaterials and Their Derivatives by Targeting Glial Cells
Glial cells, although often overlooked in comparison with neurons, play a crucial role in the structure and function of the nervous system. Their loss can lead to impairment of functions such as learning and memory, contributing to neurodegenerative diseases. To combat these diseases effectively, therapeutic strategies must restore the function of neuronal and glial cells. Natural resources offer promising therapeutic molecules for the treatment of neurodegenerative diseases. Chitosan (CTS), chitooligosaccharide (COS) and their derivatives from arthropod exoskeletons have attracted the attention of neuroscientists because of their neuroprotective effects and their ability to transport therapeutic substances across the blood-brain barrier (BBB). This chapter explores the role of natural resources in the fight against neuronal diseases. Request access from your librarian to read this chapter's full text.
- 18 December 2023
- Published by IGI Global Scientific Publishing
- p. 375-399
Investigation of Potential Neuroprotective Role of Chitosan-Based Biomaterials and Their Derivatives by Targeting Glial Cells
Glial cells, although often overlooked in comparison with neurons, play a crucial role in the structure and function of the nervous system. Their loss can lead to impairment of functions such as learning and memory, contributing to neurodegenerative diseases. To combat these diseases effectively, therapeutic strategies must restore the function of neuronal and glial cells. Natural resources offer promising therapeutic molecules for the treatment of neurodegenerative diseases. Chitosan (CTS), chitooligosaccharide (COS) and their derivatives from arthropod exoskeletons have attracted the attention of neuroscientists because of their neuroprotective effects and their ability to transport therapeutic substances across the blood-brain barrier (BBB). This chapter explores the role of natural resources in the fight against neuronal diseases. Request access from your librarian to read this chapter's full text.
- 18 December 2023
- Published by IGI Global Scientific Publishing
- p. 400-415
Chitosan Polysaccharides
Neuroinflammation is a complex, well-orchestrated process involving various groups of CNS glial cells and immune cells. Glial cells play a remarkable structural and functional role in the nervous system compared to neurons. However, neuroinflammation at the central level is a key player in various neurological disorders, including neurodegenerative diseases and CNS lesions. Therapeutic approaches to combat human neurodegenerative diseases must therefore restore neuronal and glial cell function. Natural resources are a source of potential therapeutic molecules for the treatment of neurodegenerative diseases. Currently, chitosan and its derivatives from arthropod exoskeletons are endowed with powerful anti-neuroinflammatory properties, as well as the ability to transport therapeutic substances across the BBB. This chapter discusses possible therapeutic options, the mechanism and role of chitosan in alleviating neuroinflammation at the central level, and the resulting diseases, in particular glial cell disorders. Request access from your librarian to read this chapter's full text.
- 18 December 2023
- Published by IGI Global Scientific Publishing
- p. 400-415
Chitosan Polysaccharides
Neuroinflammation is a complex, well-orchestrated process involving various groups of CNS glial cells and immune cells. Glial cells play a remarkable structural and functional role in the nervous system compared to neurons. However, neuroinflammation at the central level is a key player in various neurological disorders, including neurodegenerative diseases and CNS lesions. Therapeutic approaches to combat human neurodegenerative diseases must therefore restore neuronal and glial cell function. Natural resources are a source of potential therapeutic molecules for the treatment of neurodegenerative diseases. Currently, chitosan and its derivatives from arthropod exoskeletons are endowed with powerful anti-neuroinflammatory properties, as well as the ability to transport therapeutic substances across the BBB. This chapter discusses possible therapeutic options, the mechanism and role of chitosan in alleviating neuroinflammation at the central level, and the resulting diseases, in particular glial cell disorders. Request access from your librarian to read this chapter's full text.
- 18 December 2023
- Published by IGI Global Scientific Publishing
- p. 416-441
Chitosan-Based Biomaterials for Tissue Engineering of Glial Cells
Glial cells play a remarkable structural and functional role in the nervous system compared to neurons. However, damage to glial cells leads to degeneration and the onset of numerous neurodegenerative diseases. It is well known that the central nervous system (CNS) has a limited capacity for tissue regeneration. The use of chitosan-based biomaterials has emerged as a potential alternative solution to overcome these limitations. Interest in these biomaterials for CNS biomedical implementation has increased due to their ability to cross the BBB, their mucoadherence, and especially their hydrogel-forming capacity. In addition, their ability to form porous scaffolds and to carry cells and biomolecules has offered a means of achieving glial cell regeneration. Thus, this chapter aims to bring together recent work that highlights the potential of chitosan-based biomaterials suitable for glial cell tissue engineering. Request access from your librarian to read this chapter's full text.
- 18 December 2023
- Published by IGI Global Scientific Publishing
- p. 416-441
Chitosan-Based Biomaterials for Tissue Engineering of Glial Cells
Glial cells play a remarkable structural and functional role in the nervous system compared to neurons. However, damage to glial cells leads to degeneration and the onset of numerous neurodegenerative diseases. It is well known that the central nervous system (CNS) has a limited capacity for tissue regeneration. The use of chitosan-based biomaterials has emerged as a potential alternative solution to overcome these limitations. Interest in these biomaterials for CNS biomedical implementation has increased due to their ability to cross the BBB, their mucoadherence, and especially their hydrogel-forming capacity. In addition, their ability to form porous scaffolds and to carry cells and biomolecules has offered a means of achieving glial cell regeneration. Thus, this chapter aims to bring together recent work that highlights the potential of chitosan-based biomaterials suitable for glial cell tissue engineering. Request access from your librarian to read this chapter's full text.
- 25 September 2023
- Published by IGI Global Scientific Publishing
- p. 173-207
The Interplay Between Environmental Pollutants, Gut Microbiota, and Infections
Environmental pollutants (EPs) have become an increasingly common health hazard. Several studies have sustained the impact of these EPs on human gut microbiota (GM). The human GM is made up of thousands of microbes that play a paramount role to maintain hosts' health by providing many physiological functions, as well as protecting the host from pathogens and aggressions. Considering the crucial role that the host's GM plays in maintaining health, its disruption (gut dysbiosis) by the EPs can increase extraordinary the risk of infections and lead to the development of several conditions. Therefore, interventions aimed to restore the gut microbial population are of great interest. This chapter examines the intricate relationship between EPs and GM, highlighting the profound impact of EPs on human health including the development of infections. Additionally, this chapter discusses the potential role of probiotics, prebiotics, and FMT in mitigating the detrimental effects of EPs on GM.
- 25 September 2023
- Published by IGI Global Scientific Publishing
- p. 173-207
The Interplay Between Environmental Pollutants, Gut Microbiota, and Infections
Environmental pollutants (EPs) have become an increasingly common health hazard. Several studies have sustained the impact of these EPs on human gut microbiota (GM). The human GM is made up of thousands of microbes that play a paramount role to maintain hosts' health by providing many physiological functions, as well as protecting the host from pathogens and aggressions. Considering the crucial role that the host's GM plays in maintaining health, its disruption (gut dysbiosis) by the EPs can increase extraordinary the risk of infections and lead to the development of several conditions. Therefore, interventions aimed to restore the gut microbial population are of great interest. This chapter examines the intricate relationship between EPs and GM, highlighting the profound impact of EPs on human health including the development of infections. Additionally, this chapter discusses the potential role of probiotics, prebiotics, and FMT in mitigating the detrimental effects of EPs on GM.